# The Jules Bordet Institute Molecular Profiling Program Feasibility Trial

> **NCT01932489** · NA · COMPLETED · sponsor: **Jules Bordet Institute** · enrollment: 35 (actual)

## Conditions studied

- Colorectal Cancer Metastatic
- Metastatic Melanoma
- Metastatic Non-Small Cell Lung Carcinoma

## Interventions

- **PROCEDURE:** Biopsy of a metastatic lesion.

## Key facts

- **NCT ID:** NCT01932489
- **Lead sponsor:** Jules Bordet Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2018-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01932489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01932489, "The Jules Bordet Institute Molecular Profiling Program Feasibility Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01932489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
